Intuitive Surgical (MIL:1ISRG) Research & Development: €1,167 Mil (TTM As of Mar. 2026)


MIL:1ISRG Intuitive Surgical Inc MIL:1ISRG
74 GF Score
Price €357.15
GF Value €537.04
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Intuitive Surgical Research & Development?

Intuitive Surgical MIL:1ISRG +0.15% 74 Research & Development is €1,167 Mil as of Mar. 2026. GuruFocus rates MIL:1ISRG with a GF Score™ of 74/100 and a GF Value™ of €537.04 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Intuitive Surgical's Research & Development for the three months ended in Mar. 2026 was €313 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €1,167 Mil.

Intuitive Surgical  (MIL:1ISRG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Intuitive Surgical Research & Development Related Terms

Intuitive Surgical Research & Development Historical Data

* Premium members only.

The historical data trend for Intuitive Surgical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intuitive Surgical Research & Development Chart

Intuitive Surgical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 593.84 829.78 915.90 1,093.76 1,120.28

Intuitive Surgical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 292.49 271.63 280.65 301.38 313.04
MIL:1ISRG
74GF Score
Intuitive Surgical Inc MIL:1ISRG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intuitive Surgical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,167 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €1,167 Mil mean?
Intuitive Surgical (MIL:1ISRG) has a Research & Development of €1,167 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Intuitive Surgical and its competitors.
Is Intuitive Surgical's Research & Development too high?
Intuitive Surgical's current Research & Development is €1,167 Mil. Overall, Intuitive Surgical has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's Research & Development compare to BDX and MDLN?
Intuitive Surgical's Research & Development of €1,167 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Intuitive Surgical and its competitors. Intuitive Surgical's current Research & Development is €1,167 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (MIL:1ISRG) is currently considered Significantly Undervalued. The stock's GF Value™ is €537.04, compared to a current price of €357.15 — trading 33.5% below its estimated fair value. The current Research & Development is €1,167 Mil. Intuitive Surgical's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Intuitive Surgical (MIL:1ISRG), the current Research & Development is €1,167 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intuitive Surgical (MIL:1ISRG) Overvalued in 2026?

Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued. The current stock price of €357.15 is trading 33.5% below its estimated GF Value™ of €537.04. GuruFocus considers Intuitive Surgical to be Significantly Undervalued.

Key valuation signals for MIL:1ISRG:

  • Research & Development: €1,167 Mil
  • GF Value™: €537.04 vs. price of €357.15 (33.5% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the MIL:1ISRG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intuitive Surgical Business Description

Address 1020 Kifer Road, Sunnyvale, CA, USA, 94086
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
74GF Score

Get the complete analysis for MIL:1ISRG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€357.15
Price
€537.04
GF Value